SFC
NVS icon

Strategic Financial Concepts’s Novartis NVS Stock Holding History

Strategic Financial Concepts’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,709
Closed -$35.4K – 549
2024
Q2 		$35.4K Buy
+30,709
New +$3.08M 0.02% 276

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Strategic Financial Concepts's NVS Position: Q3 2024 in Review

Strategic Financial Concepts sold out of Novartis (NVS) in Q3 2024, closing a stake of 30,709 shares — an estimated $35.4K sold.

Strategic Financial Concepts first reported a position in NVS in Q2 2024 and held it in 1 quarter. The position peaked at $35.4K in Q2 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Strategic Financial Concepts reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • Strategic Financial Concepts sold 30,709 Novartis shares in Q3 2024, an estimated $35.4K.
  • Strategic Financial Concepts first reported a position in Novartis in Q2 2024 and held it in 1 quarter.
  • Strategic Financial Concepts's Novartis position peaked at $35.4K in Q2 2024.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Strategic Financial Concepts's 13F filing for Q3 2024, filed 12 Nov 2024.